Skip to main content
. 2022 Oct 19;12(10):1643. doi: 10.3390/life12101643

Table 6.

15-LOX inhibition capacity (%) and EC50 values of the extract and AgNPs.

Sample 0.1562 mg/mL 0.3125 mg/mL 0.625 mg/mL 1.25 mg/mL 2.5 mg/mL 5 mg/mL EC50 (µg/mL Final Solution)
Extract 8.87 ± 0.55 12.22 ± 0.53 18.88 ± 0.30 29.38 ± 1.04 45.43 ± 1.38 72.30 ± 1.75 46.90 ± 1.74 a
AgNPs 31.07 ± 0.58 41.29 ± 0.69 51.48 ± 0.44 63.93 ± 1.66 74.55 ± 1.36 98.09 ± 0.20 9.40 ± 0.30 b
Gallic acid 17.23 ± 1.69 28.15 ± 2.32 47.23 ± 1.58 61.15 ± 1.80 72.14 ± 2.81 89.25 ± 1.74 11.98 ± 0.97 a

ap < 0.0001 (extremely statistically significant) extract vs. gallic acid; b p > 0.01 (statistically significant) AgNPs vs. gallic acid.